News
According to a research Project by Spanish scientists presented in the OARSI 2013 CongressThese finding will play a key role to better understand the physiopathology of joint diseases affecting the proper functioning of cartilage and joints.The findings of seven nationwide studies presented at the OARSI Congress might serve as the basis for new osteoarthritis treatment research.
The ′Osteochip Project′ involded more than 1,700 post-menopause women aged 45 and older from France, Switzerland and Italy. This study is being developed by Bioiberica Farma, a leading Spanish biotechnology company with more than 30 years of experience in joint care under its belt. Dr.
Nearly 17% of the Andalusian population suffers from osteoarthritis, a disease that causes 35% of primary care visitsExperts will meet next Thursday in Malaga to discuss this disease and the role that pharmacists can play in monitoring its development
It was held on November 22nd, 2012 at the Faculty of Pharmacy of the Universidad de La Laguna, with some 200 healthcare professionals in attendance. There were discussed the most relevant aspects of treatments and its pharma-economics assessment, as well as the latest research news
Healthcare professionals from different areas of expertise will attend next Friday, November 30th, the 2nd conference of Clinical Rheumatology of the Spanish Society of Familial and Community Medicine. It will be held at the Meliá Lebreros Hotel in Seville, Spain.